Home/ Supplements/ Electrolytes/ Carb Intercept 3 with Phase 2 Carb Contr...

Carb Intercept 3 with Phase 2 Carb Controller

product on market Capsule Natrol Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains chromium, which has moderate evidence for supporting insulin sensitivity and glucose metabolism. The Phase 2 Carb Controller complex is designed to manage carbohydrate absorption, though comprehensive clinical data on this specific blend is limited. The product maintains a high safety profile with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Carb Intercept 3 with Phase 2 Carb Controller
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Calcium
33 mg (2% DV)
30 mcg (90% DV)
Within RDA (0.9× RDA) 199 studies (A:1, B:55)
Sodium
15 mg (1% DV)
Phase 2 Carb Controller Complex
750 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
75 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)

Other Ingredients

Hypromellose Microcrystalline Cellulose Dicalcium Phosphate Silicon Dioxide Gum Arabic Magnesium Stearate Maltodextrin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 2 capsules, two times daily, with a meal.

Warnings & Precautions

Contains: Milk, Soy

Warning: Consult your healthcare professional prior to use if you have or suspect a medical condition, or are taking prescription drugs, or are pregnant or lactating. Each serving contains as much caffeine as about 1 cup of coffee. Limit the use of caffeine-containing medication, foods or beverages while taking this product.

Too much caffeine may cause nervousness, irritability, sleeplessness and occasionally rapid heartbeat. This product is not intended/recommended for children and those sensitive to caffeine.

This product is not intended/recommended for children and those sensitive to caffeine.

Keep out of reach of children.

Formulation Notes

Contains: Milk, Soy

No: Egg, fish, crustacean shellfish, tree nuts, peanuts, wheat, artificial colors, added sugar or preservatives

Each serving contains as much caffeine as about 1 cup of coffee.

Control it! Carb Intercept 3 with Phase 2 a patented and clinically tested all-natural white kidney bean extract shown to help control carbs by reducing the enzymatic digestion of dietary starches. This is the first carbohydrate "blocker" that's clinically proven to delay the digestion of carbs, which reduces the caloric impact of starchy foods. Burn it! Carb Intercept 3, includes Green Tea and Caffeine which may help rev up metabolism and calorie-burning. Includes the antioxidant Green Tea extract to help neutralize free radicals produced by regular exercise, and Caffeine to promote energy and mental alertness. Energize it! Chromium Carb Intercept 3 also contains Chromium, which helps metabolize: Fats Carbohydrates Proteins

Clinically tested White Kidney Bean extract

Vegetarian

Clinically tested: Studies showed Phase 2 White Kidney Bean Carb Intercept to: Helps reduce the digestion and absorption of carbohydrates by up to 66% Promotes healthy body weight Reduces enzymatic digestion of dietary starches

Additional Information

Store in a cool, dry place.

New look! Weight management Helps control carbs Helps metabolize fat & protein for energy

Vegetarian

Studies recommend: Up to 3,000mg of Phase 2 Carb Controller daily 2,000 kcal/day diet and at least 30 minutes of exercise, 5 days per week Optimum results occurred between 8-12 weeks.

For detailed clinical studies, visit: www.phase2info.com

ITEM: 6081.921 F: 3003221 L: 2008870-17150

Metadata

Product Details

UPC / SKU0 47469 06081 7
DSLD Entry Date2019-09-24
Product TypeOther Combinations
FormCapsule
BrandNatrol
DSLD ID203497
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.